NOVAREX Market Cap

NOVAREX has a market cap or net worth of 217.91 billion as of March 9, 2026. Its market cap has increased by 61.97% in one year.

Market Cap

217.91B

Enterprise Value

230.37B

Revenue

385.76B

Ranking

n/a

PE Ratio

6.04

Stock Price

12,740.00

Market Cap Chart

Since November 14, 2018, NOVAREX's market cap has increased from 180.98B to 217.91B, an increase of 20.41%. That is a compound annual growth rate of 2.57%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	217.91B	-12.07%
Dec 30, 2025	247.83B	86.67%
Dec 30, 2024	132.77B	-38.22%
Dec 28, 2023	214.90B	19.61%
Dec 29, 2022	179.68B	-41.23%
Dec 30, 2021	305.72B	-1.28%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Vivozon Pharmaceutical	196.71B
DAE HWA Pharmaceutical	250.31B
OPTUS Pharmaceutical	179.29B
Organoidsciences	168.60B
GREEN CROSS WellBeing	158.82B
High Tech Pharm	154.18B
Kyung Dong Pharmaceutical	143.60B
DongKoo Bio & Pharma	138.19B

Market Cap Rankings